E. Habermann

11.3k total citations · 2 hit papers
245 papers, 8.8k citations indexed

About

E. Habermann is a scholar working on Molecular Biology, Neurology and Pharmacology. According to data from OpenAlex, E. Habermann has authored 245 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 54 papers in Neurology and 44 papers in Pharmacology. Recurrent topics in E. Habermann's work include Botulinum Toxin and Related Neurological Disorders (53 papers), Toxin Mechanisms and Immunotoxins (37 papers) and Healthcare and Venom Research (35 papers). E. Habermann is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (53 papers), Toxin Mechanisms and Immunotoxins (37 papers) and Healthcare and Venom Research (35 papers). E. Habermann collaborates with scholars based in Germany, France and United States. E. Habermann's co-authors include Joachim Jentsch, Wilfried Dimpfel, H. Breithaupt, Ulrich Weller, Florian Dreyer, Melitta Just, Hans Bigalke, Gursharan S. Chhatwal, Gudrun Ahnert‐Hilger and Piotr K. Janicki and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

E. Habermann

242 papers receiving 8.2k citations

Hit Papers

Bee and Wasp Venoms 1967 2026 1986 2006 1972 1967 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Habermann Germany 45 4.1k 1.9k 1.8k 1.5k 1.4k 245 8.8k
Mati Fridkin Israel 64 6.2k 1.5× 674 0.4× 1.1k 0.6× 3.4k 2.2× 823 0.6× 355 13.4k
Peter Højrup Denmark 54 7.1k 1.7× 957 0.5× 262 0.1× 1.1k 0.8× 1.5k 1.0× 229 12.2k
Hisashi Fujioka United States 60 5.8k 1.4× 1.1k 0.6× 586 0.3× 1.2k 0.8× 428 0.3× 193 12.0k
George A. Gutman United States 41 10.1k 2.5× 245 0.1× 838 0.5× 4.5k 3.0× 2.3k 1.6× 101 16.0k
Jean‐Marc Sabatier France 43 4.3k 1.0× 288 0.2× 576 0.3× 666 0.4× 2.0k 1.4× 234 6.9k
Howard Jaffe United States 49 4.1k 1.0× 489 0.3× 163 0.1× 1.5k 1.0× 2.1k 1.5× 140 8.2k
William A. Dunn United States 55 4.6k 1.1× 487 0.3× 359 0.2× 865 0.6× 429 0.3× 111 9.6k
Toshiaki Isobe Japan 62 10.1k 2.5× 537 0.3× 567 0.3× 1.0k 0.7× 694 0.5× 247 13.4k
J. Michael Conlon United States 61 8.2k 2.0× 309 0.2× 1.3k 0.7× 5.9k 3.9× 1.5k 1.1× 647 18.1k
Kunihiro Matsumoto Japan 87 20.1k 4.9× 585 0.3× 1.1k 0.6× 2.1k 1.4× 1.5k 1.0× 233 29.2k

Countries citing papers authored by E. Habermann

Since Specialization
Citations

This map shows the geographic impact of E. Habermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Habermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Habermann more than expected).

Fields of papers citing papers by E. Habermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Habermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Habermann. The network helps show where E. Habermann may publish in the future.

Co-authorship network of co-authors of E. Habermann

This figure shows the co-authorship network connecting the top 25 collaborators of E. Habermann. A scholar is included among the top collaborators of E. Habermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Habermann. E. Habermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofmann, Fred, et al.. (1995). Sequencing and analysis of the gene encoding the α-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. Molecular and General Genetics MGG. 247(6). 670–679. 28 indexed citations
2.
3.
Habermann, E., et al.. (1992). Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(3). 358–61. 23 indexed citations
4.
Hudel, Martina, et al.. (1992). Increase of permeability of synaptosomes and liposomes by the heavy chain of tetanus toxin. Toxicon. 30(1). 63–76. 13 indexed citations
5.
Habermann, E., Ulrich Weller, & Martina Hudel. (1991). Limited proteolysis of single-chain tetanus toxin by tissue enzymes, in cultured brain tissue and during retrograde axonal to the spinal cord. Naunyn-Schmiedeberg s Archives of Pharmacology. 343(3). 323–9. 7 indexed citations
6.
Hofmann, Fred & E. Habermann. (1990). Role of ?-conotoxin-sensitive calcium channels in inositolphosphate production and noradrenaline release due to potassium depolarization or stimulation with carbachol. Naunyn-Schmiedeberg s Archives of Pharmacology. 341(3). 200–5. 14 indexed citations
7.
Habermann, E., et al.. (1989). Effects of botulinum A toxin on presynaptic modulation of evoked transmitter release. European Journal of Pharmacology. 164(1). 45–53. 33 indexed citations
8.
Ahnert‐Hilger, Gudrun, et al.. (1989). The tetanus toxin light chain inhibits exocytosis. FEBS Letters. 242(2). 245–248. 98 indexed citations
9.
Weller, Ulrich, et al.. (1989). Chains and fragments of tetanus toxin. European Journal of Biochemistry. 182(3). 649–656. 62 indexed citations
11.
Habermann, E. & B. G. Müller. (1989). Oxoferin® und Natriumchlorit — Ein Vergleich. Journal of Molecular Medicine. 67(1). 20–25. 4 indexed citations
12.
Habermann, E.. (1989). Palytoxin acts through Na+, K+-ATPase. Toxicon. 27(11). 1171–1187. 185 indexed citations
13.
Weller, Ulrich, et al.. (1988). Tetanus toxin: Biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis. Naunyn-Schmiedeberg s Archives of Pharmacology. 338(2). 99–106. 42 indexed citations
14.
Habermann, E. & Karin Fischer. (1979). Apamin, a centrally acting neurotoxic peptide: binding and actions.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 3. 387–94. 6 indexed citations
15.
Habermann, E., et al.. (1978). Structure-activity studies on apamin and mast cell degranulating peptide (MCDP)-401 [proceedings].. PubMed. 284. 160P–161P. 7 indexed citations
16.
Habermann, E.. (1972). Bee and Wasp Venoms. Science. 177(4046). 314–322. 1331 indexed citations breakdown →
17.
Urbanitz, D., Herbert Wiegand, & E. Habermann. (1969). Zur Frage der Bedeutung des Kininsystems beim thermischen dem der Rattenpfote@@@Investigations of the significance of the kinin system in the thermic edema of the bat paw. Naunyn-Schmiedeberg s Archives of Pharmacology. 264(4). 476–493. 5 indexed citations
18.
Habermann, E.. (1968). [Biochemistry, pharmacology and toxicology of substances contained in Hymenoptera poisons].. PubMed. 60. 220–325. 7 indexed citations
19.
Habermann, E.. (1957). [Extraction and properties of crotactin, phospholipase A, crotamine and toxin III from the venom of the Brazilian rattlesnake].. PubMed. 329(5). 405–15. 10 indexed citations
20.
Habermann, E., et al.. (1955). [Crotactin, the main toxin from venom from the Brazilian rattlesnake, Crotalus terrificus terrificus].. PubMed. 327(3). 170–85. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026